NYSE, AGN - Allergan Plc
We are a multi-specialty health care company focused on developing and
commercializing innovative pharmaceuticals, biologics and medical devices that
enable people to see more clearly, move more freely and express themselves more
fully. Our diversified approach enables us to follow our research and
development into new specialty areas where unmet needs are significant.
We discover, develop and commercialize specialty pharmaceutical, medical device
and over-the-counter products for the ophthalmic, neurological, medical
aesthetics, medical dermatological, breast aesthetics, obesity intervention,
urological and other specialty markets in more than 100 countries around the
world. We are a pioneer in specialty pharmaceutical research, targeting products
and technologies related to specific disease areas such as glaucoma, retinal
disease, chronic dry eye, psoriasis, acne, movement disorders, neuropathic pain
and genitourinary diseases. ...
Read SEC Filing on NASDAQ.com »